JPMorgan Asian Investment Trust plc - Ordinary Shares - J.P. Morgan Asset Management
JPMorgan Asian Investment Trust plc


Targeting income without compromising on Asia’s growth

JPMorgan Asian Investment Trust plc provides access to the world’s fastest growing equity market and targets predictable quarterly income without compromising its focus on growth.

Morningstar 5 star             *

Monthly Factsheet   Other trust documents   How to buy this trust  

Why invest in Asia?

Ayaz Ebrahim, Fund Manager of JPMorgan Asia Investment Trust plc discusses the opportunities and challenges of investing in Asia.

Some of the themes discussed include:

  • Transformation of the sector and market
  • Rise and opportunity of technology
  • The impact of China debt and trade with the US
Monthly Factsheet    Annual Report    Learn more about investing in the Far East  

JPMorgan Asian Investment Trust in the news

By sharing this third-party content, J.P. Morgan Asset Management does not endorse or attest to its completeness and accuracy; and the content does not necessarily represent the views of J.P. Morgan Asset Management.

About this trust



Performance widget loading ...


Fees widget loading ...


Portfolio widget loading ...

Manager Commentary

Fund Managers

Month in review

  • The portfolio outperformed the benchmark during the month, largely on the back of positive stock selection.
  • Asian equities suffered a sharp selloff in October amid global weakness emanating from the U.S.. Negative headlines on deteriorating U.S.-China trade tensions, a spike in global yields and a resurgent U.S. dollar joined the persistent overhangs of weak China macro data and liquidity over the month.
  • Korea, Taiwan and China equities dragged on regional performance, while the Association of Southeast Asian Nations (ASEAN) and India fared better.
  • By country, stock selection in Korea was the key contributor over the month. Emart outperformed thanks to its defensiveness, and we continue to believe its e-commerce business potential is undervalued. Samsung Fire & Marine benefited from growing expectations for easing regulatory pressure. Not owning bio stocks such as Celltrion and Samsung BioLogics contributed as both stocks suffered from correction post-outperformance over the last several months.
  • Turning to detractors, stock selection in China and Hong Kong was a headwind to performance. WuXi Biologics continued to fall on the back of negative sentiment across the Chinese pharmaceutical sector, while PICC Property & Casualty corrected with weaker-than-expected third-quarter 2018 earnings due to higher commissions in auto insurance.
  • In terms of country allocation, the overweight position in Indonesia contributed, while zero exposure to Malaysia detracted.
  • Looking ahead

  • The near-term path of markets will likely depend on whether the dollar continues to rally and the market’s views on the likelihood of agreement between the U.S. and China on trade. After rebounding meaningfully into the summer, the dollar index has remained range-bound, and we continue to believe that U.S. economic fundamentals do not support further dollar strength.
  • Documents

    How to buy this trust

    Learn More

    Find out more

    For contact details and more information on our trust range use the following links:

    Contact us   View our other investment trusts   Our investment trust awards  

    Investor Insights

    Receive monthly articles, research and views from J.P. Morgan Asset Management.

    Sign up by emailRead related articles   

    AGM information

    Annual General Meeting: 26th February 2018 at 12.30 p.m at 60 Victoria Embankment, London, EC4Y 0JP.

    Important information

    This is a marketing communication and as such the views contained herein are not to be taken as an advice or recommendation to buy or sell any investment or interest thereto. Reliance upon information in this material is at the sole discretion of the reader. Any research in this document has been obtained and may have been acted upon by J.P. Morgan Asset Management for its own purpose. The results of such research are being made available as additional information and do not necessarily reflect the views of J.P. Morgan Asset Management. Any forecasts, figures, opinions, statements of financial market trends or investment techniques and strategies expressed are unless otherwise stated, J.P. Morgan Asset Management’s own at the date of this document. They are considered to be reliable at the time of writing, may not necessarily be all inclusive and are not guaranteed as to accuracy. They may be subject to change without reference or notification to you. It should be noted that the value of investments and the income from them may fluctuate in accordance with market conditions and taxation agreements and investors may not get back the full amount invested. Changes in exchange rates may have an adverse effect on the value, price or income of the products or underlying overseas investments. Past performance and yield are not reliable indicators of current and future results. There is no guarantee that any forecast made will come to pass. Furthermore, whilst it is the intention to achieve the investment objective of the investment products, there can be no assurance that those objectives will be met. J.P. Morgan Asset Management is the brand name for the asset management business of JPMorgan Chase & Co. and its affiliates worldwide. To the extent permitted by applicable law, we may record telephone calls and monitor electronic communications to comply with our legal and regulatory obligations and internal policies. Personal data will be collected, stored and processed by J.P. Morgan Asset Management in accordance with our EMEA Privacy Policy

    Investment is subject to documentation. The Investor Disclosure Document, and Key Features / Terms & Conditions can be obtained free of charge from JPMorgan Asset Management (UK) Limited, and the Key Information Document can be obtained from JPMorgan Funds Limited or This communication is issued by JPMorgan Asset Management (UK) Limited, which is authorised and regulated in the UK by the Financial Conduct Authority. Registered in England No: 01161446. Registered address: 25 Bank Street, Canary Wharf, London E14 5JP.

    *Morningstar Analyst rating and FE Crown rating as at 01 November 2018.

    FE Crown Fund Ratings © 2018 FE. All rights reserved.

    Moneyfacts award as at: 17 October 2017. ©2017 Moneyfacts Group plc. All Rights Reserved.

    © 2017 All Rights Reserved.

    Moneywise Investment Trust awards as at: 28 March 2018. Moneywise Publishing Ltd ©2018. All Rights Reserved.

    Past performance is not a reliable indicator of current and future results.